Ethiopia Completes Marburg Vaccine Trial, Analyzes Results: Technical Lead.
The trial included 631 people at risk who were exposed to the virus, with 518 successfully completing the process, Dr. Mezgebu, the trial's technical lead at the Armauer Hansen Research Institute, told Sputnik Africa on the sidelines of the 28th annual review meeting of the health sector in Hoshana.
Key facts about the trial, according to the spokesman:
An innovative approach: Conducted during an actual outbreak, the trial uniquely combined research with routine medical care, and produced encouraging results.
Next steps: Researchers are currently analyzing the collected samples before officially publishing the findings in various channels.
Strategic Impact: The initiative marks a crucial step in strengthening Ethiopia's national capacity to investigate and respond to future public health emergencies.
Sign up for .
Sputnik Africa | X.